PRESS RELEASE published on 01/08/2025 at 15:21, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.49% interest in Direct Line Insurance Group plc. Purchase of ordinary shares made on 07 Jan 2025 at 2.59 GBP per unit The Vanguard Group Financial Disclosure Share Purchase Direct Line Insurance Group Plc 5.49% Interest
BRIEF published on 01/07/2025 at 15:06, 1 year 8 months ago Vanguard Group Discloses Position in Direct Line Insurance Group Takeover Code Vanguard Group Stake Disclosure Direct Line Insurance Securities Position
BRIEF published on 01/07/2025 at 15:06, 1 year 8 months ago Le groupe Vanguard révèle sa position dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Divulgation Des Enjeux Position Des Titres Assurance Ligne Directe
PRESS RELEASE published on 01/07/2025 at 15:01, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.49% ownership in Direct Line Insurance Group plc. Disclosure under Rule 8.3 of the Takeover Code The Vanguard Group, Inc. Rule 8.3 Takeover Code Ownership Disclosure Direct Line Insurance Group Plc
BRIEF published on 01/06/2025 at 15:23, 1 year 8 months ago The Vanguard Group Discloses Position in Direct Line Insurance Group Form 8.3 Vanguard Group Public Disclosure Shareholding Direct Line Insurance
BRIEF published on 01/06/2025 at 15:23, 1 year 8 months ago Le groupe Vanguard révèle sa position dans Direct Line Insurance Group Actionnariat Groupe Vanguard Divulgation Publique Formulaire 8.3 Assurance Ligne Directe
PRESS RELEASE published on 01/06/2025 at 15:18, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses holding 5.49% stake in Direct Line Insurance Group plc as of 03 January 2025 Vanguard Group Financial Disclosure Stake Disclosure Direct Line Insurance Ownership Percentage
BRIEF published on 01/03/2025 at 15:59, 1 year 8 months ago The Vanguard Group Declares Position in Direct Line Insurance Group Disclosure Takeover Code Vanguard Group Direct Line Insurance Securities Position
BRIEF published on 01/03/2025 at 15:59, 1 year 8 months ago Le groupe Vanguard déclare sa position dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Divulgation Position Des Titres Assurance Ligne Directe
PRESS RELEASE published on 01/03/2025 at 15:54, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.49% ownership in Direct Line Insurance Group plc. Purchase and sale details included Vanguard Group Inc. Ownership Disclosure Direct Line Insurance Group Plc Purchase Details Sale Details
Published on 09/11/2026 at 04:00, 6 hours 15 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 50 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 55 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 15 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 54 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 9 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 15 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 15 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 hours 15 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 15 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 45 minutes ago Availability of the 2026 Interim Financial Report
